Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4G4E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,126
Award facts
- Contract value 100% obligated
- $19,125.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $19,125.83 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Monovisc 88 mg/4 ml syringes. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026.
Place of performance is Conshohocken, PA. The ultimate completion date is February 11, 2026. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26F4G4E?
SPE2DR26F4G4E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 10, 2026.
How much is contract SPE2DR26F4G4E worth?
The government has obligated $19,126 on SPE2DR26F4G4E.
Is contract SPE2DR26F4G4E an order under another contract?
Yes. SPE2DR26F4G4E is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4G4E competed?
The extent of competition for SPE2DR26F4G4E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award